Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 7Recruiting 4Unknown 3Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Aberrant Crypt Foci 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 16Early Intervention, Educational 16Methods 15Cyclophosphamide 15Surgical Procedures, Operative 14Standard of Care 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Cisplatin 11Filgrastim 10Educational Status 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Gemcitabine 8X-Rays 7Sorafenib 7Practice Guidelines as Topic 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Terminated × Curcumin × Clear all
NCT00003365 2011-01-27

Sulindac and Plant Compounds in Preventing Colon Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00176618 2009-12-11

The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon

Rutgers, The State University of New Jersey

Phase NA Terminated
60 enrolled

Aberrant Crypt Foci

Data powered by HemOnc (CC BY 4.0) Colophon âš¡